Prediction of response of methotrexate in patients with rheumatoid arthritis using serum lipidomics

Methotrexate (MTX) is a common first-line treatment for new-onset rheumatoid arthritis (RA). However, MTX is ineffective for 30–40% of patients and there is no way to know which patients might benefit. Here, we built statistical models based on serum lipid levels measured at two time-points (pre-tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Maciejewski, Mateusz, Sands, Caroline, Nair, Nisha, Ling, Stephanie, Verstappen, Suzanne, Hyrich, Kimme, Barton, Anne, Ziemek, Daniel, Lewis, Matthew R., Plant, Darren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8012618/
https://www.ncbi.nlm.nih.gov/pubmed/33790392
http://dx.doi.org/10.1038/s41598-021-86729-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8012618/
https://www.ncbi.nlm.nih.gov/pubmed/33790392
http://dx.doi.org/10.1038/s41598-021-86729-7

Ejemplares similares